These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 29958681)

  • 41. Development of Impurity Profiling Methods Using Modern Analytical Techniques.
    Ramachandra B
    Crit Rev Anal Chem; 2017 Jan; 47(1):24-36. PubMed ID: 27070830
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification and structure elucidation of a new degradation impurity in the multi-component tablets of amlodipine besylate.
    Gibala P; Douša M; Kalužíková A; Tkadlecová M; Štefko M; Kalášek S; Břicháč J
    J Pharm Biomed Anal; 2019 Jan; 162():112-116. PubMed ID: 30236818
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization and relative response factor determination of process related impurity in Naproxen by nuclear magnetic resonance spectroscopy.
    Iqbal MY; Rao KM; Sridhar G; Raju PP; Deshpande GR; Babu JM
    J Pharm Biomed Anal; 2011 Nov; 56(3):484-90. PubMed ID: 21782369
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preparative two-dimensional liquid chromatography/mass spectrometry for the purification of complex pharmaceutical samples.
    Zhang Y; Zeng L; Pham C; Xu R
    J Chromatogr A; 2014 Jan; 1324():86-95. PubMed ID: 24309715
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improved liquid chromatographic method for quality control of spiramycin using superficially porous particles.
    Lin Q; Kahsay G; de Waal T; Zhu P; Tam M; Teughels R; Wang W; Van Schepdael A; Adams E
    J Pharm Biomed Anal; 2018 Feb; 149():57-65. PubMed ID: 29101816
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Determination of epoxide impurity in sarpogrelate hydrochloride intermediate by UHPLC and column-switching liquid chromatography.
    Wang R; Zhu Z; Qiu X; Bai L; Guo W; Zuo L; Zhao T; Shan G
    J Pharm Biomed Anal; 2019 Sep; 174():57-62. PubMed ID: 31154094
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LC determination of impurities in methoxsalen drug substance: isolation and identification of isopimpinellin as a major impurity by atmospheric pressure chemical ionization LC/MS and NMR.
    Lehr GJ; Barry TL; Franolic JD; Petzinger G; Scheiner P
    J Pharm Biomed Anal; 2003 Nov; 33(4):627-37. PubMed ID: 14623588
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isolation and characterization of a potential process related impurity of phenazopyridine HCl by preparative HPLC followed by MS-MS and 2D-NMR spectroscopy.
    Rao RN; Maurya PK; Raju AN
    J Pharm Biomed Anal; 2009 Jul; 49(5):1287-91. PubMed ID: 19376664
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification and characterization of a principal oxidation impurity in clopidogrel drug substance and drug product.
    Mohan A; Hariharan M; Vikraman E; Subbaiah G; Venkataraman BR; Saravanan D
    J Pharm Biomed Anal; 2008 May; 47(1):183-9. PubMed ID: 18313249
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comprehensive analysis of pharmaceutical products using simultaneous mixed-mode (ion-exchange/reversed-phase) and hydrophilic interaction liquid chromatography.
    Kazarian AA; Nesterenko PN; Soisungnoen P; Burakham R; Srijaranai S; Paull B
    J Sep Sci; 2014 Aug; 37(16):2138-44. PubMed ID: 24890905
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of impurities in semi-synthetic vinorelbine bitartrate by HPLC-MS with mass spectrometric shift technique.
    Cao X; Tai Y; Sun C; Wang K; Pan Y
    J Pharm Biomed Anal; 2005 Sep; 39(1-2):39-45. PubMed ID: 16085133
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Investigation and structural elucidation of a process related impurity in candesartan cilexetil by LC/ESI-ITMS and NMR.
    Raman B; Sharma BA; Mahale G; Singh D; Kumar A
    J Pharm Biomed Anal; 2011 Sep; 56(2):256-63. PubMed ID: 21664089
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of degradation products in stressed tablets of Rabeprazole sodium by HPLC-hyphenated techniques.
    Vasu Dev R; Sai Uday Kiran G; Venkata Subbaiah B; Suresh Babu B; Moses Babu J; Dubey PK; Vyas K
    Magn Reson Chem; 2009 May; 47(5):443-8. PubMed ID: 19173350
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of a new impurity in lisinopril.
    Shinde V; Trivedi A; Upadhayay PR; Gupta NL; Kanase DG; Chikate R
    J Pharm Biomed Anal; 2007 Jan; 43(1):381-6. PubMed ID: 16926080
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NDMA impurity in valsartan and other pharmaceutical products: Analytical methods for the determination of N-nitrosamines.
    Parr MK; Joseph JF
    J Pharm Biomed Anal; 2019 Feb; 164():536-549. PubMed ID: 30458387
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Separation and characterization of allergenic polymerized impurities from cephalosporin for injection by trap free two-dimensional high performance size exclusion chromatography × reversed phase liquid chromatography coupled with ion trap time-of-flight mass spectrometry.
    Xu Y; Wang D; Zhu B; Tang L; Wang J
    J Pharm Biomed Anal; 2018 May; 154():425-432. PubMed ID: 29579634
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Method development and validation study for quantitative determination of 2-chloromethyl-3,4-dimethoxy pyridine hydrochloride a genotoxic impurity in pantoprazole active pharmaceutical ingredient (API) by LC/MS/MS.
    Venugopal N; Bhaskar Reddy AV; Gangadhar Reddy K; Madhavi V; Madhavi G
    J Pharm Biomed Anal; 2012 Nov; 70():592-7. PubMed ID: 22749172
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High-resolution two-dimensional liquid chromatography analysis of key linker drug intermediate used in antibody drug conjugates.
    Venkatramani CJ; Huang SR; Al-Sayah M; Patel I; Wigman L
    J Chromatogr A; 2017 Oct; 1521():63-72. PubMed ID: 28942996
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optimization of a liquid chromatography method for the analysis of related substances in daclatasvir tablets using design of experiments integrated with the steepest ascent method and Monte Carlo simulation.
    Tol T; Tawde H; Gorad S; Jagdale A; Kulkarni A; Kasbale A; Desai A; Samanta G
    J Pharm Biomed Anal; 2020 Jan; 178():112943. PubMed ID: 31677954
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.